Monitoring the stability of the standardization status of FT4 and TSH assays by use of daily outpatient medians and flagging frequencies.

Clinicians diagnose thyroid dysfunction based on TSH and FT4 testing. However, the current lack of comparability between assays limits the optimal use of laboratory data. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) gave a mandate to the Committee for Standardization of Thyroid Function Tests (C-STFT) to resolve this limitation by standardization. Recently, the Committee members and their partners felt ready to set the step towards the technical recalibration. However, before implementation, they were furthered by the Food and Drugs Administration (FDA) to develop a tool to assess the sustainability of the new calibration basis. C-STFT began to use 2 online applications, i.e., the "Percentiler" and "Flagger", with the intention to assess their utility for this purpose. The tools monitor the course of instrument-specific moving medians of outpatient results (Percentiler) and flagging rates (Flagger) from data of individual laboratories grouped by instrument/assay peer. They additionally document the mid- to long-term medians, hence, are quality indicators of stability of performance of both laboratories and peers/assays. Here, the first experiences built up in the pre-standardization phase are reported. They suggest the suitability of both applications to document the sustainability of the calibration basis in the post-standardization phase.

[1]  L. Thienpont,et al.  Standardization activities in the field of thyroid function tests: a status report , 2010, Clinical chemistry and laboratory medicine.

[2]  M. Vanderpump,et al.  The epidemiology of thyroid disease. , 2011, British medical bulletin.

[3]  K. Midthjell,et al.  Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). , 2000, European journal of endocrinology.

[4]  L. Thienpont,et al.  Standardization of Free Thyroxine and Harmonization of Thyrotropin Measurements: A Request for Input from Endocrinologists and Other Physicians , 2015, Thyroid : official journal of the American Thyroid Association.

[5]  L. Thienpont,et al.  On-line flagging monitoring – a new quality management tool for the analytical phase , 2015, Clinical chemistry and laboratory medicine.

[6]  Dietmar Stöckl,et al.  A statistical basis for harmonization of thyroid stimulating hormone immunoassays using a robust factor analysis model , 2014, Clinical chemistry and laboratory medicine.

[7]  M. Rottmann,et al.  A Progress Report of the IFCC Committee for Standardization of Thyroid Function Tests , 2014, European Thyroid Journal.

[8]  Dietmar Stöckl,et al.  The Empower project – a new way of assessing and monitoring test comparability and stability , 2015, Clinical chemistry and laboratory medicine.

[9]  L. Thienpont,et al.  Use of frozen sera for FT4 standardization: investigation by equilibrium dialysis combined with isotope dilution-mass spectrometry and immunoassay. , 2006, Clinical chemistry.

[10]  Hubert W Vesper,et al.  Traceability in laboratory medicine. , 2009, Clinical chemistry.

[11]  Kenneth Goossens,et al.  Monitoring laboratory data across manufacturers and laboratories--A prerequisite to make "Big Data" work. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[12]  M. Rottmann,et al.  Measurement of free thyroxine in laboratory medicine – proposal of measurand definition , 2007, Clinical chemistry and laboratory medicine.

[13]  J. Thijssen,et al.  Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 3: total thyroxine and total triiodothyronine. , 2010, Clinical chemistry.

[14]  A. Morris,et al.  Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS) , 2007, Clinical endocrinology.

[15]  W Greg Miller,et al.  Commutability limitations influence quality control results with different reagent lots. , 2011, Clinical chemistry.

[16]  W Greg Miller,et al.  Commutability still matters. , 2013, Clinical chemistry.

[17]  L. Thienpont,et al.  IFCC international conventional reference procedure for the measurement of free thyroxine in serum , 2011, Clinical chemistry and laboratory medicine.

[18]  T. Fiers,et al.  Long-term stability of laboratory tests and practical implications for quality management , 2013, Clinical chemistry and laboratory medicine.

[19]  M. Rottmann,et al.  Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum , 2007, Clinical chemistry and laboratory medicine.

[20]  J. Thijssen,et al.  Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 1: thyroid-stimulating hormone. , 2010, Clinical chemistry.

[21]  P. Twomey,et al.  A fresh look at analytical performance specifications from biological variation. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[22]  Karen A Robinson,et al.  Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. , 2009, The Journal of clinical endocrinology and metabolism.

[23]  Linda M Thienpont,et al.  A "Step-Up" approach for harmonization. , 2014, Clinica chimica acta; international journal of clinical chemistry.